The Biotech industry has been flat over the last week, but Telix Pharmaceuticals has lost 3.2%. The past year has been better, since the industry has gained 12% in that time. As for the next few years, earnings are expected to grow by 20% per annum.
Has the Australian Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 30 May 2023 | AU$157.4b | AU$18.4b | AU$2.4b | 40.4x | 66x | 8.6x |
Thu, 27 Apr 2023 | AU$156.3b | AU$18.2b | AU$2.3b | 41.8x | 66.6x | 8.6x |
Sat, 25 Mar 2023 | AU$146.9b | AU$18.1b | AU$2.3b | 39.3x | 62.7x | 8.1x |
Mon, 20 Feb 2023 | AU$151.9b | AU$17.3b | AU$2.3b | 51.3x | 66.5x | 8.8x |
Wed, 18 Jan 2023 | AU$148.4b | AU$15.5b | AU$2.5b | 52.2x | 60.5x | 9.6x |
Fri, 16 Dec 2022 | AU$151.7b | AU$15.9b | AU$2.5b | 46.9x | 59.9x | 9.5x |
Sun, 13 Nov 2022 | AU$149.4b | AU$16.1b | AU$2.6b | 45.4x | 58.5x | 9.3x |
Tue, 11 Oct 2022 | AU$144.3b | AU$16.8b | AU$2.7b | 40.7x | 53.4x | 8.6x |
Thu, 08 Sep 2022 | AU$149.5b | AU$15.8b | AU$2.5b | 44.6x | 59.4x | 9.5x |
Sat, 06 Aug 2022 | AU$151.3b | AU$15.5b | AU$2.8b | 41.6x | 54.2x | 9.8x |
Mon, 04 Jul 2022 | AU$135.9b | AU$15.9b | AU$2.9b | 34.5x | 47.3x | 8.6x |
Wed, 01 Jun 2022 | AU$137.8b | AU$15.0b | AU$2.7b | 36.5x | 51.2x | 9.2x |
Fri, 29 Apr 2022 | AU$136.3b | AU$15.1b | AU$2.8b | 36.3x | 49.4x | 9x |
Sun, 27 Mar 2022 | AU$135.1b | AU$14.3b | AU$2.6b | 39.4x | 52.1x | 9.4x |
Tue, 22 Feb 2022 | AU$136.0b | AU$15.0b | AU$2.7b | 39.2x | 50.2x | 9.1x |
Thu, 20 Jan 2022 | AU$140.5b | AU$14.6b | AU$2.8b | 39.2x | 50.6x | 9.6x |
Sat, 18 Dec 2021 | AU$142.1b | AU$14.6b | AU$2.8b | 39.5x | 51.3x | 9.8x |
Mon, 15 Nov 2021 | AU$153.3b | AU$14.3b | AU$2.7b | 43.2x | 56.7x | 10.7x |
Wed, 13 Oct 2021 | AU$145.1b | AU$14.2b | AU$2.7b | 41.4x | 54.1x | 10.2x |
Fri, 10 Sep 2021 | AU$150.1b | AU$14.0b | AU$2.6b | 43.5x | 57.2x | 10.7x |
Sun, 08 Aug 2021 | AU$146.2b | AU$14.0b | AU$2.6b | 42.8x | 55.7x | 10.5x |
Sat, 01 May 2021 | AU$132.5b | AU$13.5b | AU$2.8b | 37.3x | 46.8x | 9.8x |
Tue, 02 Feb 2021 | AU$132.3b | AU$13.1b | AU$3.0b | 35.8x | 44.2x | 10.1x |
Fri, 06 Nov 2020 | AU$138.5b | AU$13.5b | AU$2.9b | 31.2x | 48.1x | 10.2x |
Mon, 10 Aug 2020 | AU$130.3b | AU$13.5b | AU$2.7b | 40.3x | 48.9x | 9.7x |
44.6x
How does Australian Biotech compare with similar industries?
AU Market | -0.72% | |
Healthcare | -0.40% | |
Biotech | 0.088% | |
Biotech | 0.088% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ARX Aroa Biosurgery | AU$1.00 | 8.7% +AU$27.4m | 27.4% | PS7.2x | |
PAB Patrys | AU$0.012 | 20.0% +AU$4.1m | -46.7% | PS7x | |
CYP Cynata Therapeutics | AU$0.14 | 11.5% +AU$2.7m | -63.7% | PS10x | |
NSB NeuroScientific Biopharmaceuticals | AU$0.11 | 11.1% +AU$1.6m | -54.2% | PS13.6x | |
TRP Tissue Repair | AU$0.28 | 10.0% +AU$1.5m | -1.8% | PS96.7x |